Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy for Locally Advanced and Borderline Resectable Pancreatic Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation
Int. J. Radiat. Oncol. Biol. Phys 2022 Jul 18;[EPub Ahead of Print], EJ Koay, M Zaid, M Aliru, P Bagereka, A Van Wieren, MJ Rodriguez, G Jacobson, RA Wolff, M Overman, G Varadhachary, S Pant, H Wang, CW Tzeng, N Ikoma, M Kim, JE Lee, MH Katz, E Tamm, P Bhosale, CM Taniguchi, EB Holliday, GL Smith, EB Ludmir, BD Minsky, CH Crane, AC Koong, P Das, X Wang, M Javle, S KrishnanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.